Regulus Therapeutics Inc. — Revenue by Fiscal Year
12 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/9c2306f6-7ea6-4965-843d-6b2133a3a6a6/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2021 | $0 | 2021-01-01 – 2021-12-31 | evidence 0001628280-22-005771 |
| FY 2020 | $10.0M | 2020-01-01 – 2020-12-31 | evidence 0001628280-21-004294 |
| FY 2019 | $6.8M | 2019-01-01 – 2019-12-31 | evidence 0001628280-20-003483 |
| FY 2018 | $72.0k | 2018-01-01 – 2018-12-31 | evidence 0001628280-19-003037 |
| FY 2017 | $72.0k | 2017-01-01 – 2017-12-31 | evidence 0001628280-19-003037 |
| FY 2016 | $1.2M | 2016-01-01 – 2016-12-31 | evidence 0001628280-19-003037 |
| FY 2015 | $20.8M | 2015-01-01 – 2015-12-31 | evidence 0001628280-16-011521 |
| FY 2014 | $7.7M | 2014-01-01 – 2014-12-31 | evidence 0001193125-15-052948 |
| FY 2013 | $19.6M | 2013-01-01 – 2013-12-31 | evidence 0001193125-14-074001 |
| FY 2012 | $12.7M | 2012-01-01 – 2012-12-31 | evidence 0001193125-13-065164 |
| FY 2011 | $13.8M | 2011-01-01 – 2011-12-31 | evidence 0001193125-13-065164 |
| FY 2010 | $8.6M | 2010-01-01 – 2010-12-31 | evidence 0001193125-13-065164 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
Regulus Therapeutics Inc. — all facts · Net Income · Operating Income